Mobocertinib (TAK788)
Mobocertinib (TAK788, AP32788), an investigational TKI, is a potent, selective preclinical inhibitor of epidermal growth factor receptor (EGFR) and HER2 mutations. Mobocertinib (TAK788) is an antineoplastic agent.
Supplier | Selleck Chemicals |
---|---|
Product # | S6813 |
Sku # | S6813-25mg |
Pricing | 25mg, $237.00 |